Safety and Feasibility of Fasting While Receiving Chemotherapy

February 24, 2010 updated by: King Fahad Medical City
Fasting (refraining from eating and drinking) during the day is safe while receiving chemotherapy.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Riyadh, Saudi Arabia, 11525
        • King Fahad Medical City

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Fasting patients who are schedulled to receive chemotherapy during the month of Ramadan

Description

Inclusion Criteria:

  • Age > 18 years
  • Established diagnosis of cancer
  • Signed informed consent
  • Adequate CBC and chemistry to receive chemotherapy

Exclusion Criteria:

  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
I
Patients planning to observe fasting while receiving chemotherapy during the month of Ramadan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Safety of fasting while receiving chemotherapy
Time Frame: two months
two months

Secondary Outcome Measures

Outcome Measure
Time Frame
Effect of fasting on chemotherapy side effects
Time Frame: two months
two months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali SM Al-Shanqeeti, MD, King Fahad Medical City

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2008

Primary Completion (Actual)

December 1, 2008

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

September 19, 2008

First Submitted That Met QC Criteria

September 19, 2008

First Posted (Estimate)

September 22, 2008

Study Record Updates

Last Update Posted (Estimate)

February 25, 2010

Last Update Submitted That Met QC Criteria

February 24, 2010

Last Verified

February 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • KFMC IRB-08-040

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe